We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$347B
AUM Growth
+$49B
Cap. Flow
+$12.7B
Cap. Flow %
3.67%
Top 10 Hldgs %
25.82%
Holding
11,328
New
1,232
Increased
3,827
Reduced
4,449
Closed
1,709

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.33B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$781M
3
TSLA icon
Tesla
TSLA
+$468M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$467M
5
HD icon
Home Depot
HD
+$344M

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.94%
3 Communication Services 1.89%
4 Healthcare 1.12%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRP
9401
CALL
DELISTED
Neurotrope, Inc. Common
NTRP
$28K ﹤0.01%
28,600
-111,400
-80% -$86.9K
NTRP
9402
DELISTED
Neurotrope, Inc. Common
NTRP
$28K ﹤0.01%
+27,713
New +$21.6K
CLUB
9403
DELISTED
Town Sports International Holdings, Inc.
CLUB
$28K ﹤0.01%
+16,532
New +$28.6K
QHC
9404
PUT
DELISTED
Quorum Health Corporation
QHC
$28K ﹤0.01%
+29,000
New +$28.4K
CTST
9405
CALL
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$28K ﹤0.01%
30,100
-89,100
-75% -$88.6K
JILL icon
9406
J. Jill
JILL
$295M
$27K ﹤0.01%
4,811
+2,387
+98% +$18.7K
TRVN
9407
DELISTED
Trevena, Inc.
TRVN
$27K ﹤0.01%
52
+14
+37% +$7.18K
SB icon
9408
Safe Bulkers
SB
$886M
$26K ﹤0.01%
15,245
-17,246
-53% -$30K
ZDGE icon
9409
Zedge
ZDGE
$38.4M
$26K ﹤0.01%
+17,115
New +$29.3K
TDW.WS.A
9410
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$26K ﹤0.01%
+15,632
New +$20.1K
NTRP
9411
PUT
DELISTED
Neurotrope, Inc. Common
NTRP
$26K ﹤0.01%
26,200
-9,100
-26% -$7.1K
CTXR icon
9412
Citius Pharmaceuticals
CTXR
$16.6M
$25K ﹤0.01%
+971
New +$14.2K
INDP icon
9413
CALL
Indaptus Therapeutics
INDP
$145M
$25K ﹤0.01%
22
-8
-27% -$11K
PDS
9414
Precision Drilling
PDS
$1.12B
$25K ﹤0.01%
+901
New +$20.7K
PULM icon
9415
Pulmatrix
PULM
$5.84M
$25K ﹤0.01%
+1,435
New +$22.8K
VIRX
9416
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$25K ﹤0.01%
2,109
-31
-1% -$519
VOLT
9417
PUT
DELISTED
Volt Information Sciences, Inc.
VOLT
$25K ﹤0.01%
+10,000
New +$27.8K
CLDX icon
9418
CALL
Celldex Therapeutics
CLDX
$3.24B
$24K ﹤0.01%
10,600
-600
-5% -$1.39K
KXIN icon
9419
Kaixin Holdings
KXIN
$9.1M
0
VUZI icon
9420
CALL
Vuzix
VUZI
$231M
$24K ﹤0.01%
11,800
+1,700
+17% +$3.85K
ZVRA icon
9421
Zevra Therapeutics
ZVRA
$715M
$24K ﹤0.01%
4,031
-2,510
-38% -$19.9K
THWWW
9422
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$24K ﹤0.01%
46,600
IDEX
9423
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$24K ﹤0.01%
+225
New +$30K
TALO.WS
9424
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$24K ﹤0.01%
+14,706
New +$14.5K
ACET icon
9425
CALL
Adicet Bio
ACET
$84.3M
$23K ﹤0.01%
+140
New +$70.9K

Similar funds

Jeff Yass's Q4 2019 Portfolio in Review

As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.

  • Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
  • Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
  • Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
  • Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
  • Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
  • Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.